clavulanic acid has been researched along with cilastatin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Roselle, GA | 1 |
| Jansen, GJ; Slootmaker-van der Meulen, G; Welling, G | 1 |
| Gannon, P; Mucciardi, N; Sesin, GP | 1 |
| Bur, F; Donahue, PE; Luke, DR; Mintz, SJ; Smith, DL; Yellin, AE | 1 |
| Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
| Butler-Laporte, G; Menzies, D; Winters, N | 1 |
1 review(s) available for clavulanic acid and cilastatin
| Article | Year |
|---|---|
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
1 trial(s) available for clavulanic acid and cilastatin
| Article | Year |
|---|---|
Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
Topics: Abdomen; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cilastatin; Clavulanic Acid; Double-Blind Method; Female; Fluoroquinolones; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Naphthyridines; Penicillins; Prospective Studies; Protease Inhibitors; Surgical Wound Infection; Thienamycins; Treatment Outcome | 1998 |
6 other study(ies) available for clavulanic acid and cilastatin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Nosocomial and nursing home-acquired pneumonia. Recent therapeutic advances.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Cilastatin; Clavulanic Acid; Clavulanic Acids; Cross Infection; Cyclopropanes; Humans; Imipenem; Nursing Homes; Pneumonia; Thienamycins; Ticarcillin | 1987 |
Inactivation of imipenem by faecal fractions from human volunteers and the effect of clavulanate and cilastatin.
Topics: Anti-Bacterial Agents; Biotransformation; Cilastatin; Clavulanic Acid; Clavulanic Acids; Feces; Humans; Imipenem | 1993 |
Ticarcillin-clavulanate as an alternative to imipenem-cilastatin.
Topics: Bacterial Infections; Cilastatin; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Imipenem; Protease Inhibitors; Ticarcillin | 1995 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |